Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 803752, 8 pages
http://dx.doi.org/10.1155/2015/803752
Review Article

Pruritus in Systemic Diseases: A Review of Etiological Factors and New Treatment Modalities

Department of Dermatology, Okmeydanı Training and Research Hospital, 34384 Istanbul, Turkey

Received 20 February 2015; Revised 11 June 2015; Accepted 16 June 2015

Academic Editor: Uwe Wollina

Copyright © 2015 Nagihan Tarikci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. J. Shanley, “Pathophysiology of pruritus,” Veterinary Clinics of North America. Small Animal Practice, vol. 18, no. 5, pp. 971–981, 1988. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Yonova, “Pruritus in certain internal diseases,” Hippokratia, vol. 11, no. 2, pp. 67–71, 2007. View at Google Scholar · View at Scopus
  3. H. Navaz, “Itch: a symptom of occult disease,” Australian Family Physician, vol. 33, no. 7, pp. 495–499, 2004. View at Google Scholar · View at Scopus
  4. T. S. Patel, B. I. Freedman, and G. Yosipovitch, “An update on pruritus associated with CKD,” The American Journal of Kidney Diseases, vol. 50, no. 1, pp. 11–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Narita, S. Iguchi, K. Omori, and F. Gejyo, “Uremic pruritus in chronic hemodialysis patients,” Journal of Nephrology, vol. 21, no. 2, pp. 161–165, 2008. View at Google Scholar · View at Scopus
  6. J. C. Szepietowski and J. Salomon, “Uremic pruritus: still an important clinical problem,” Journal of the American Academy of Dermatology, vol. 51, no. 5, pp. 842–843, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. E. A. S. Attia and A. A. Hassan, “Uremic pruritus pathogenesis, revisited,” Arab Journal of Nephrology and Transplantation, vol. 7, no. 2, pp. 91–99, 2014. View at Google Scholar
  8. F. Aucella, M. Vigilante, and A. Gesuete, “Review: the effect of polymethylmethacrylate dialysis membranes on uraemic pruritus,” NDT Plus, vol. 3, supplement 1, pp. i8–i11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Morton, M. Lafferty, C. Hau, I. Henderson, M. Jones, and J. G. Lowe, “Pruritus and skin hydration during dialysis,” Nephrology Dialysis Transplantation, vol. 11, no. 10, pp. 2031–2036, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Yosipovitch, J. Reis, E. Tur, E. Sprecher, D. Yarnitsky, and G. Boner, “Sweat secretion, stratum corneum hydration, small nerve function and pruritus in patients with advanced chronic renal failure,” British Journal of Dermatology, vol. 133, no. 4, pp. 561–564, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ståhle-Bäckdahl, “Uremic pruritus. Clinical and experimental studies,” Acta Dermato-Venereologica, Supplement, vol. 145, pp. 1–38, 1989. View at Google Scholar · View at Scopus
  12. I. Zucker, G. Yosipovitch, M. David, U. Gafter, and G. Boner, “Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease,” Journal of the American Academy of Dermatology, vol. 49, no. 5, pp. 842–846, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. R. L. Pisoni, B. Wikström, S. J. Elder et al., “Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS),” Nephrology Dialysis Transplantation, vol. 21, no. 12, pp. 3495–3505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. C. De Filippi, R. Regazzini, V. Piazza et al., “Uraemic pruritus is not related to plasma histamine concentrations,” Clinical and Experimental Dermatology, vol. 20, no. 4, pp. 294–296, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. S. De Marchi, E. Cecchin, D. Villalta, G. Sepiacci, G. Santini, and E. Bartoli, “Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia,” The New England Journal of Medicine, vol. 326, no. 15, pp. 969–974, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. S. G. Massry, M. M. Popovtzer, J. W. Coburn, D. L. Makoff, M. H. Maxwell, and C. R. Kleeman, “Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy,” The New England Journal of Medicine, vol. 279, no. 13, pp. 697–700, 1968. View at Publisher · View at Google Scholar · View at Scopus
  17. C. L. Hampers, A. I. Katz, R. E. Wilson, and J. P. Merrill, “Disappearance of ‘uremic’ itching after subtotal parathyroidectomy.,” The New England Journal of Medicine, vol. 279, no. 13, pp. 695–697, 1968. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Jedras, B. Zakrzewska-Pniewska, K. Wardyn, and M. Świtalski, “Uremic neuropathy—part II. Is pruritus in dialyzed patients related to neuropathy?” Polskie Archiwum Medycyny Wewnetrznej, vol. 99, no. 6, pp. 462–469, 1998. View at Google Scholar · View at Scopus
  19. D.-C. Tarng, Y.-L. Cho, H.-N. Liu, and T.-P. Huang, “Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream,” Nephron, vol. 72, no. 4, pp. 617–622, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Ständer, C. Moormann, M. Schumacher et al., “Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures,” Experimental Dermatology, vol. 13, no. 3, pp. 129–139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. W. Greaves, “Itch in systemic disease: therapeutic options,” Dermatologic Therapy, vol. 18, no. 4, pp. 323–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. D. R. Kuypers, K. Claes, P. Evenepoel, B. Maes, and Y. Vanrenterghem, “A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy,” Nephrology Dialysis Transplantation, vol. 19, no. 7, pp. 1895–1901, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-C. Chen, W.-T. Chiu, and M.-S. Wu, “Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus,” The American Journal of Kidney Diseases, vol. 48, no. 1, pp. 69–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. G. Berger and M. Steinhoff, “Pruritus and renal failure,” Seminars in Cutaneous Medicine and Surgery, vol. 30, no. 2, pp. 99–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Wang and G. Yosipovitch, “New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma,” International Journal of Dermatology, vol. 49, no. 1, pp. 1–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Mettang and E. Weisshaar, “Pruritus: control of itch in patients undergoing dialysis,” Skin Therapy Letter, vol. 15, no. 2, pp. 1–5, 2010. View at Google Scholar · View at Scopus
  27. H. Umeuchi, Y. Togashi, T. Honda et al., “Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system,” European Journal of Pharmacology, vol. 477, no. 1, pp. 29–35, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Q. Phan, J. D. Bernhard, T. A. Luger, and S. Ständer, “Antipruritic treatment with systemic μ-opioid receptor antagonists: a review,” Journal of the American Academy of Dermatology, vol. 63, no. 4, pp. 680–688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. P. Davis, J. L. Frandsen, D. Walsh, S. Andresen, and S. Taylor, “Mirtazapine for pruritus,” Journal of Pain and Symptom Management, vol. 25, no. 3, pp. 288–291, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. L. Hundley and G. Yosipovitch, “Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study,” Journal of the American Academy of Dermatology, vol. 50, no. 6, pp. 889–891, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. I. Gunal, G. Ozalp, T. K. Yoldas, S. Y. Gunal, E. Kirciman, and H. Celiker, “Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial,” Nephrology Dialysis Transplantation, vol. 19, no. 12, pp. 3137–3139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. R. B. Silva, P. C. F. Viana, N. V. Lugon, M. Hoette, F. Ruzany, and J. R. Lugon, “Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial,” Nephron, vol. 67, no. 3, pp. 270–273, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Murphy and A. J. Carmichael, “Renal itch,” Clinical and Experimental Dermatology, vol. 25, no. 2, pp. 103–106, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Bunchorntavakul and K. R. Reddy, “Pruritus in chronic cholestatic liver disease,” Clinics in Liver Disease, vol. 16, no. 2, pp. 331–346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Rishe, A. Azarm, and N. V. Bergasa, “Itch in primary biliary cirrhosis: a patients' perspective,” Acta Dermato-Venereologica, vol. 88, no. 1, pp. 34–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. N. V. Bergasa, “Pruritus in chronic liver disease: Mechanisms and treatment,” Current Gastroenterology Reports, vol. 6, no. 1, pp. 10–16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. N. V. Bergasa, “Pruritus in primary biliary cirrhosis: pathogenesis and therapy,” Clinics in Liver Disease, vol. 12, no. 2, pp. 385–406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. N. V. Bergasa, “Pruritus and fatigue in primary biliary cirrhosis,” Clinics in Liver Disease, vol. 7, no. 4, pp. 879–900, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. M. H. Imam, A. A. Gossard, E. Sinakos, and K. D. Lindor, “Pathogenesis and management of pruritus in cholestatic liver disease,” Journal of Gastroenterology and Hepatology, vol. 27, no. 7, pp. 1150–1158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. N. V. Bergasa, “The itch of liver disease,” Seminars in Cutaneous Medicine and Surgery, vol. 30, no. 2, pp. 93–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Bolier, R. P. J. Oude Elferink, and U. Beuers, “Advances in pathogenesis and treatment of pruritus,” Clinics in Liver Disease, vol. 17, no. 2, pp. 319–329, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. G. M. Murphy, A. Ross, and B. H. Billing, “Serum bile acids in primary biliary cirrhosis,” Gut, vol. 13, no. 3, pp. 201–206, 1972. View at Publisher · View at Google Scholar · View at Scopus
  43. M. W. Greaves, “Pathogenesis and treatment of pruritus,” Current Allergy and Asthma Reports, vol. 10, no. 4, pp. 236–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. E. Kremer, R. Bolier, R. Van Dijk, R. P. J. Oude Elferink, and U. Beuers, “Advances in pathogenesis and management of pruritus in cholestasis,” Digestive Diseases, vol. 32, no. 5, pp. 637–645, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Tandon, B. H. Rowe, B. Vandermeer, and V. G. Bain, “The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus,” American Journal of Gastroenterology, vol. 102, no. 7, pp. 1528–1536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. B. T. Summey Jr. and G. Yosipovitch, “Pharmacologic advances in the systemic treatment of itch,” Dermatologic Therapy, vol. 18, no. 4, pp. 328–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. A. E. Kremer, J. J. W. W. Martens, W. Kulik et al., “Lysophosphatidic acid is a potential mediator of cholestatic pruritus,” Gastroenterology, vol. 139, no. 3, pp. 1008.e1–1018.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. R. P. J. O. Elferink, A. E. Kremer, J. J. W. W. Martens, and U. H. Beuers, “The molecular mechanism of cholestatic pruritus,” Digestive Diseases, vol. 29, no. 1, pp. 66–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. A. E. Kremer, R. van Dijk, P. Leckie et al., “Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions,” Hepatology, vol. 56, no. 4, pp. 1391–1400, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. G. B. Sherard III and S. M. Atkinson Jr., “Focus on primary care: pruritic dermatological conditions in pregnancy,” Obstetrical and Gynecological Survey, vol. 56, no. 7, pp. 427–432, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Twycross, M. W. Greaves, H. Handwerker et al., “Itch: scratching more than the surface,” QJM, vol. 96, no. 1, pp. 7–26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. S. D. Gittlen, E. S. Schulman, and W. C. Maddrey, “Raised histamine concentrations in chronic cholestatic liver disease,” Gut, vol. 31, no. 1, pp. 96–99, 1990. View at Google Scholar · View at Scopus
  53. A. Lonsdale-Eccles and A. J. Carmichael, “Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies,” Drugs and Aging, vol. 20, no. 3, pp. 197–208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. D. V. Datta and S. Sherlock, “Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis.,” Gastroenterology, vol. 50, no. 3, pp. 323–332, 1966. View at Google Scholar · View at Scopus
  55. A. Podesta, P. Lopez, R. Terg et al., “Treatment of pruritus of primary biliary cirrhosis with rifampin,” Digestive Diseases and Sciences, vol. 36, no. 2, pp. 216–220, 1991. View at Publisher · View at Google Scholar · View at Scopus
  56. J. R. Bloomer and J. L. Boyer, “Phenobarbital effects in cholestatic liver disease,” Annals of Internal Medicine, vol. 82, no. 3, pp. 310–317, 1975. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Dillon and J. D. Tobias, “Ondansetron to treat pruritus due to cholestatic jaundice,” The Journal of Pediatric Pharmacology and Therapeutics, vol. 18, no. 3, pp. 241–346, 2013. View at Publisher · View at Google Scholar
  58. M. J. Mayo, I. Handem, S. Saldana, H. Jacobe, Y. Getachew, and A. J. Rush, “Sertraline as a first-line treatment for cholestatic pruritus,” Hepatology, vol. 45, no. 3, pp. 666–674, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. A. G. Villamil, J. C. Bandi, O. A. Galdame, S. Gerona, and A. C. Gadano, “Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases,” American Journal of Medicine, vol. 118, no. 10, pp. 1160–1163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Yosipovitch, “Chronic pruritus: a paraneoplastic sign,” Dermatologic Therapy, vol. 23, no. 6, pp. 590–596, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. E. Alpsoy, “Paraneoplastic pruritus and paraneoplastic erythroderma,” Turkdem-Archives of the Turkish Dermatology and Venerology, vol. 47, pp. 65–68, 2013. View at Google Scholar
  62. M. Rubenstein and M. Duvic, “Cutaneous manifestations of Hodgkin's disease,” International Journal of Dermatology, vol. 45, no. 3, pp. 251–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. S. H. Omidvari, H. N. Khojasteh, M. Mohammadianpanah, A. Monabati, A. Mosalaei, and N. Ahmadloo, “Long-term pruritus as the initial and sole clinical manifestation of occult Hodgkin's disease,” Indian Journal of Medical Sciences, vol. 58, no. 6, pp. 250–252, 2004. View at Google Scholar · View at Scopus
  64. C. W. Lober, “Pruritus and malignancy,” Clinics in Dermatology, vol. 11, no. 1, pp. 125–128, 1993. View at Publisher · View at Google Scholar · View at Scopus
  65. P. G. Gobbi, G. Attardo-Parrinello, G. Lattanzio, S. C. Rizzo, and E. Ascari, “Severe pruritus should be a B-symptom in Hodgkin's disease,” Cancer, vol. 51, no. 10, pp. 1934–1936, 1983. View at Publisher · View at Google Scholar · View at Scopus
  66. C. L. Bartus and S. R. S. Parker, “Hodgkin lymphoma presenting as generalized pruritus in an adolescent,” Cutis, vol. 87, no. 4, pp. 169–172, 2011. View at Google Scholar · View at Scopus
  67. N. K. K. King, H. P. P. Siriwardana, J. D. Coyne, and A. K. Siriwardena, “Intractable pruritus associated with insulinoma in the absence of multiple endocrine neoplasia: a novel paraneoplastic phenomenon,” Scandinavian Journal of Gastroenterology, vol. 38, no. 6, pp. 678–680, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Valsecchi and T. Cainelli, “Generalized pruritus: a manifestation of iron deficiency,” Archives of Dermatology, vol. 119, no. 8, article 630, 1983. View at Publisher · View at Google Scholar · View at Scopus
  69. B. M. Karnath, “Pruritus: a sign of underlying disease,” Hospital Physician, vol. 41, p. 25, 2005. View at Google Scholar
  70. F. P. Siegel, J. Tauscher, and P. E. Petrides, “Aquagenic pruritus in polycythemia vera: characteristics and influence on quality of life in 441 patients,” American Journal of Hematology, vol. 88, no. 8, pp. 665–669, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. T. Heitkemper, T. Hofmann, N. Q. Phan, and S. Ständer, “Aquagenic pruritus: associated diseases and clinical pruritus characteristics,” Journal der Deutschen Dermatologischen Gesellschaft, vol. 8, no. 10, pp. 797–805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. F. Diehn and A. Tefferi, “Pruritus in polycythaemia vera: prevalence, laboratory correlates and management,” British Journal of Haematology, vol. 115, no. 3, pp. 619–621, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. K. S. Saini, M. M. Patnaik, and A. Tefferi, “Polycythemia vera-associated pruritus and its management,” European Journal of Clinical Investigation, vol. 40, no. 9, pp. 828–834, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. N. Jackson, D. Burt, J. Crocker, and B. Boughton, “Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus,” British Journal of Dermatology, vol. 116, no. 1, pp. 21–29, 1987. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Pieri, C. Bogani, P. Guglielmelli et al., “The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera,” Haematologica, vol. 94, no. 11, pp. 1537–1545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. O. A. Lin, Z. A. Karim, H. P. Vemana, E. V. P. Espinosa, and F. T. Khasawneh, “The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function,” PLoS ONE, vol. 9, no. 1, Article ID e87026, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. R. T. Silver, “Long-term effects of the treatment of polycythemia vera with recombinant interferon-α,” Cancer, vol. 107, no. 3, pp. 451–458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. M. K. Hasan, W. M. Tierney, and M. Z. Baker, “Severe cholestatic jaundice in hyperthyroidism after treatment with 131-iodine,” American Journal of the Medical Sciences, vol. 328, no. 6, pp. 348–350, 2004. View at Google Scholar · View at Scopus
  79. G. E. Mullin and J. S. Eastern, “Cutaneous signs of thyroid disease,” American Family Physician, vol. 34, no. 4, pp. 93–98, 1986. View at Google Scholar · View at Scopus
  80. M. Ståhle-Bäckdahl, O. Hagermark, L.-E. Lins, O. Torring, M. Hilliges, and O. Johansson, “Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uraemic pruritus,” Journal of Internal Medicine, vol. 225, no. 6, pp. 411–415, 1989. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Krajnik and Z. Zylicz, “Understanding pruritus in systemic disease,” Journal of Pain and Symptom Management, vol. 21, no. 2, pp. 151–168, 2001. View at Publisher · View at Google Scholar · View at Scopus
  82. A. B. Sener, E. Kuscu, N. C. Seckin et al., “Postmenopausal vulvar pruritus—colposcopic diagnosis and treatment,” Journal of the Pakistan Medical Association, vol. 45, no. 12, pp. 315–317, 1995. View at Google Scholar · View at Scopus
  83. S. L. C. Serling, K. Leslie, and T. Maurer, “Approach to pruritus in the adult HIV-positive patient,” Seminars in Cutaneous Medicine and Surgery, vol. 30, no. 2, pp. 101–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. F. Milazzo, S. Piconi, C. Magni et al., “Intractable pruritus in HIV infection: immunologic characterization,” Allergy, vol. 54, no. 3, pp. 266–272, 1999. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Maticic, M. Poljak, T. Lunder, K. Rener-sitar, and L. Stojanovic, “Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area,” Journal of the European Academy of Dermatology and Venereology, vol. 22, no. 7, pp. 779–788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Moses, “Pruritus,” The American Family Physician, vol. 68, no. 6, pp. 1135–1145, 2003. View at Google Scholar · View at Scopus